TriangleNCT05510908 · OUTCOME
Number of Cancers in People With HIV (PWH) Who Present for Care at Domestic AMC Sites
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- Enrollment
What was measured
For each cancer group listed below, the number of new and existing cases per month will be estimated. The distribution of cancer types will be computed as percentages and compared to the cancer type distribution in the HIV/AIDS Cancer Match (HACM) Study: 1. Solid organ tumors associated with human papillomavirus (HPV) infection 2. Solid organ tumors unrelated to HPV 3. Kaposi sarcoma 4. Hematologic malignancies
Groups in this outcome
New, Primary or Recurrent Disease
Considering or currently receiving cancer treatment Non-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review. Non-Interventional Follow-up: Participants initiating or receiving ongoing treatment for their cancer will attend a single follow-up visit to recollect broad demographic and clinical data. Data collection at study visits will occur via survey procedures and/or medical record review.
Metastic or Locally Advanced Cancer
This includes cases for which there are no current definitive therapy options for cure (i.e., inoperable) but may be considered for non-standard / non-curative therapies. Non-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review. Non-Interventional Follow-up: Participants initiating or receiving ongoing treatment for their cancer will attend a single follow-up visit to recollect broad demographic and clinical data. Data collection at study visits will occur via survey procedures and/or medical record review.
Prior Cancer
Prior diagnosis (within 5 years), in remission - Not currently on cancer treatment other than ART or maintenance therapy. Non-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review.
| Group | Source count |
|---|---|
| New, Primary or Recurrent Disease | 268 |
| Metastic or Locally Advanced Cancer | 33 |
| Prior Cancer | 159 |
Reported measurements
Source class 1
Hematologic malignancies
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| New, Primary or Recurrent Disease | 43 | Not reported | Not reported | Not reported | Not reported |
| Metastic or Locally Advanced Cancer | 0 | Not reported | Not reported | Not reported | Not reported |
| Prior Cancer | 35 | Not reported | Not reported | Not reported | Not reported |
Kaposi sarcoma
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| New, Primary or Recurrent Disease | 87 | Not reported | Not reported | Not reported | Not reported |
| Metastic or Locally Advanced Cancer | 6 | Not reported | Not reported | Not reported | Not reported |
| Prior Cancer | 15 | Not reported | Not reported | Not reported | Not reported |
Solid organ tumor associated with HPV infection
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| New, Primary or Recurrent Disease | 30 | Not reported | Not reported | Not reported | Not reported |
| Metastic or Locally Advanced Cancer | 10 | Not reported | Not reported | Not reported | Not reported |
| Prior Cancer | 32 | Not reported | Not reported | Not reported | Not reported |
Solid organ tumors unrelated HPV
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| New, Primary or Recurrent Disease | 55 | Not reported | Not reported | Not reported | Not reported |
| Metastic or Locally Advanced Cancer | 13 | Not reported | Not reported | Not reported | Not reported |
| Prior Cancer | 55 | Not reported | Not reported | Not reported | Not reported |
Other
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| New, Primary or Recurrent Disease | 52 | Not reported | Not reported | Not reported | Not reported |
| Metastic or Locally Advanced Cancer | 4 | Not reported | Not reported | Not reported | Not reported |
| Prior Cancer | 22 | Not reported | Not reported | Not reported | Not reported |
Unknown
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| New, Primary or Recurrent Disease | 1 | Not reported | Not reported | Not reported | Not reported |
| Metastic or Locally Advanced Cancer | 0 | Not reported | Not reported | Not reported | Not reported |
| Prior Cancer | 0 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 43
- group Id
- OG001
- value
- 0
- group Id
- OG002
- value
- 35
- title
- Hematologic malignancies
- measurements
- group Id
- OG000
- value
- 87
- group Id
- OG001
- value
- 6
- group Id
- OG002
- value
- 15
- title
- Kaposi sarcoma
- measurements
- group Id
- OG000
- value
- 30
- group Id
- OG001
- value
- 10
- group Id
- OG002
- value
- 32
- title
- Solid organ tumor associated with HPV infection
- measurements
- group Id
- OG000
- value
- 55
- group Id
- OG001
- value
- 13
- group Id
- OG002
- value
- 55
- title
- Solid organ tumors unrelated HPV
- measurements
- group Id
- OG000
- value
- 52
- group Id
- OG001
- value
- 4
- group Id
- OG002
- value
- 22
- title
- Other
- measurements
- group Id
- OG000
- value
- 1
- group Id
- OG001
- value
- 0
- group Id
- OG002
- value
- 0
- title
- Unknown
- denoms
- counts
- group Id
- OG000
- value
- 268
- group Id
- OG001
- value
- 33
- group Id
- OG002
- value
- 159
- units
- Participants
- description
- For each cancer group listed below, the number of new and existing cases per month will be estimated. The distribution of cancer types will be computed as percentages and compared to the cancer type distribution in the HIV/AIDS Cancer Match (HACM) Study: 1. Solid organ tumors associated with human papillomavirus (HPV) infection 2. Solid organ tumors unrelated to HPV 3. Kaposi sarcoma 4. Hematologic malignancies
- groups
- description
- Considering or currently receiving cancer treatment Non-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review. Non-Interventional Follow-up: Participants initiating or receiving ongoing treatment for their cancer will attend a single follow-up visit to recollect broad demographic and clinical data. Data collection at study visits will occur via survey procedures and/or medical record review.
- id
- OG000
- title
- New, Primary or Recurrent Disease
- description
- This includes cases for which there are no current definitive therapy options for cure (i.e., inoperable) but may be considered for non-standard / non-curative therapies. Non-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review. Non-Interventional Follow-up: Participants initiating or receiving ongoing treatment for their cancer will attend a single follow-up visit to recollect broad demographic and clinical data. Data collection at study visits will occur via survey procedures and/or medical record review.
- id
- OG001
- title
- Metastic or Locally Advanced Cancer
- description
- Prior diagnosis (within 5 years), in remission - Not currently on cancer treatment other than ART or maintenance therapy. Non-Interventional: Participants will be identified via screening of electronic medical records or institutional databases. All eligible participants will have one visit for the collection of broad demographic and clinical data. Data collection at study visit will occur via survey procedures and/or medical record review.
- id
- OG002
- title
- Prior Cancer
- param Type
- COUNT_OF_PARTICIPANTS
- reporting Status
- POSTED
- time Frame
- Enrollment
- title
- Number of Cancers in People With HIV (PWH) Who Present for Care at Domestic AMC Sites
- type
- PRIMARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice